| Abstract: | This report discusses US biologicals demand for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, technological and product development, regulatory considerations, market environment, product and market forecasts, industry composition and leading participants. Product segments include recombinant proteins, monoclonal antibodies (Mabs), vaccines, blood and blood derivatives, and other biologicals; market segments cover pharmacy, ambulatory health care, hospital, other health care markets, and other markets. This 20 page report also includes a highlights summary and a resources section.
|
| Brief Excerpt: | ...Biologics demand in the US is expected to increase 10.8 percent per year between 2004 and 2009 to $74.5 billion. Gains will benefit from continued growth in national health expenditures, medical conditions and the resident population. ric f the pharmaceutical industry and the adoption of healthier lifestyles. h 2009, with demand advanc ing 15.5 percent per year to cast period due to the continued introduction of new products that can be used to treat cancer, rheumatoid ket sing 13. 2 percent per year to $26.6 billion. Demand will be aided by advances in biopharmaceuticals and egin being sold between In 2004, the leading suppliers of biol ogics to the US market were Amgen, Johnson & Johnson and Sanof i-Aventis (France). Through 2009, gains will be limited by the expected movem ent of gene biologics to the market, government regulations, public mi strust o Monoclonal antibodies is expected to be the fastest growing product segment throug $18.9 billion....
|
| Industry: | Life Sciences (Pharmaceuticals/Medical)
|
| SIC: | 2833, 2835, 2836
|
| NAICS: | 325411, 325413, 325414
|
| Company(ies): | Abbott Laboratories Incorporated, Amgen Incorporated, AstraZeneca plc, CSL Limited, Dow Chemical Company, GlaxoSmithKline plc, Johnson & Johnson, Lilly (Eli) and Company, Lonza Group Limited, Merck & Company Incorporated, Novartis International AG, Pfizer Incorporated, Roche Holding Limited, Sanofi-Aventis SA, Takeda Pharmaceutical Company Limited, Wyeth
|
| Ticker(s): | 4502, ABT, AMGN, AZN, CSL, DOW, GSK, JNJ, LLY, LONN, MRK, NVS, PFE, ROG, SNY, WYE
|
| Country(ies): | United States, US
|
| Free Sample: |
Click Here to Download
|
| Format: | | PDF |  |
|
